X

2018 ASCPT Board of Directors Appointments

Published on 2/2/2018 9:21:00 AM


ASCPT is pleased to announce that beginning in March 2018, Daniel L. Hartman, MD, FCCP, will serve a 1-year term as President of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Click here for more information.

   

David Y. Mitchell, PhD, has been appointed President-Elect of ASCPT. Dr. Mitchell has been an active member of ASCPT since 1997, serving on the Board of Directors and the Finance, Nominating, Webinar, and Education Committees. Click here for more information.

 
Also joining the Board of Directors as of March 2018 are:

Brian Corrigan, PhD is one of the newest members of the ASCPT Board of Directors.  Dr. Corrigan will serve a 3-year term as an at-large director. Click here for more information.
   

Jean-Michel Gries, MBA, PhD, PharmD, is one of the newest members of the ASCPT Board of Directors. Dr. Gries will serve a 3-year term as an at-large director. Click here for more information.

   

Lei Zhang, PhD is one of the newest members of the ASCPT Board of Directors. Dr. Zhang will be completing the unexpired term left by David Mitchell when he becomes President-Elect. Click here for more information.

print
Sort by:
Photo Gallery
Recent News
  • A Unique Collection of State-of-the-Art Pharmacometric and Systems Pharmacology Approaches in Rare Diseases Pharmacology and Therapeutics
    November 16, 2018
  • New Board Members Appointed
    November 15, 2018
  • ASCPT Members-Only Webinar Presented by the Pharmacogenomics Community (PGx)
    November 14, 2018
Contact Us